Tiziana Life Sciences(NASDAQ:TLSA) 
Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclona...
Website: http://www.tizianalifesciences.com
Founded: 1998
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.98
H 1.03
L 0.88
C 0.94
V 427,659
10EMA 0.94
20EMA 0.94
60EMA 0.94
120EMA 0.94
250EMA 0.94